China NMPA Drug Inspection - Xinjiang Qikang Habo Zhongwei Medicinal Herbs Co., Ltd. - Xipaimaizipzi Oral Solution
China NMPA drug inspection for Xinjiang Qikang Habo Zhongwei Medicinal Herbs Co., Ltd. published May 10, 2018. Drug: Xipaimaizipzi Oral Solution. The Xinjiang Uygur Autonomous Region Food and Drug Administration (XJFDA) announced results in May 2018 from its 2017 dr
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
China NMPA drug inspection for Xinjiang Qikang Habo Zhongwei Medicinal Herbs Co., Ltd. published May 10, 2018. Drug: Xipaimaizipzi Oral Solution. The Xinjiang Uygur Autonomous Region Food and Drug Administration (XJFDA) announced results in May 2018 from its 2017 dr
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox